Author: Newsbit

  • EchoStar bond issues worsen as Dish Network fails to pay interest payments

    EchoStar bond issues worsen as Dish Network fails to pay interest payments

    EchoStar Corp., the wireless and pay-TV operator controlled by billionaire Charlie Ergen, has decided to skip interest payments on three bonds after a similar act late last week.

    A total of $183 million interest payments due Monday on several bonds related to its pay-TV operator unit Dish Network Corp. will not be paid, according to a regulatory filing. The company cited “uncertainty” raised by the Federal Communications Commission review. The company has been tied up in a regulatory probe over its compliance with obligations to build a nationwide 5G network.

    EchoStar’s shares fell 3.6% in postmarket trading on Monday. Dish’s 7.75% note due 2026 dropped over 1 cent to 84 cents on the dollar, according to Trace data.

    The company has a 30-day grace period to make the interest payment. The company is skipping the payment to “allow time for the FCC to provide the relief requested,” it said.

    Ergen was locked in a dispute with Dish’s bondholders last year, after a group of creditors rejected a bond-exchange offer that would have helped facilitate a proposed acquisition by rival DirecTV. The deal would have required lenders to take a steep haircut on the debt that they owned. Bloomberg

  • Delhi High Court permits Star India to quickly forbid downloaded apps & sites

    Delhi High Court permits Star India to quickly forbid downloaded apps & sites

    Taking a significant step to combat online piracy, the Delhi High Court has issued an injunction order – which is considered a stronger version of the traditional Dynamic + injunction.

    So that fake websites and mobile apps illegally streaming the ongoing IPL and other cricket matches can be blocked forever.

    Justice Saurabh Banerjee gave this unique order in a case filed by Star India Private Limited, which has exclusive streaming rights for high-profile cricket tournaments including the Indian Premier League (IPL) and India’s tour of England. The court restrained the defendants from infringing the rights of Star India and allowed relief at the present time against websites and mobile applications involved in unauthorized broadcasting, even if it is discovered during legal proceedings.

    “In the age of new technology, today it has become very easy and convenient for infringers to create alpha-numeric/mirror/redirect variants of infringing websites…In such circumstances, this Court has repeatedly held that there is a need for relief in real time,” – Delhi High Court in Star India Pvt Ltd & Ors vs JioLive TV & Ors (2023)

    This is the first time that the Delhi High Court has granted such legal relief to a fake mobile application, marking a significant development in the fight against digital piracy. In the previous case, Star India Pvt Ltd vs https://crichdplayer.org & Ors (2025), the Court had granted injunction in real time, but only against fake websites, not against mobile apps.

    However, in the present case, the Court observed:

    “There is neither any obstruction nor any harm caused…If the same relief as granted in the cases of fake websites is extended to fake mobile applications as well…then the manner of use/dissemination activity is hardly a matter of concern.”

    The suit originally involved four known defendants, with Star India also naming several unknown rogue websites. As the case progressed, Star India filed seven interlocutory applications covering three fake mobile applications and 16 fake domains/URLs/UIs.

    The timing of the case was significant, as Star India highlighted the challenge of discovering new fake entities in real time during court holidays, particularly during the IPL and other major tournaments. The Court accepted this argument, and acknowledged the difficulty of repeatedly approaching the Court for new relief.

    It recognised the evolving nature of piracy, where infringing platforms – both websites and apps – become instantly visible during time-sensitive events such as live cricket matches.

    “Superior injunctions open an additional avenue for plaintiffs to obtain present-day relief against the infringing activities of ‘fictitious’ defendants, regardless of the modus operandi,”
    — Delhi High Court

    By granting this present-day blocking power, the Court has strengthened the enforcement of intellectual property rights in India’s sports broadcasting industry, sending a strong signal against digital piracy through both web platforms and mobile applications.

    Case no.: CS(COMM) 108/2025

    Case title: Star India Pvt Ltd v. IPTV Smarter Pro & Ors.

    Appearance: Mr. Sidharth Chopra, Mr. Yatinder Garg, Ms. Disha Sharma and Ms. Rimjhim Tiwari and Ms. Isha Singh, Advs for Plaintiff; Mr. Avish Sharma, Adv. for D-1, 4 & 36. Ms. Mrinal Ojha, Mr. Debarshi Dutta, Mr. Arjun Mookerjee, Ms. Nikita Rathi and Mr. Nikhil Gupta, Advs. for D-7.  Court Book

  • Keysight must sell its tech assets before the US will buy Spirent

    Keysight must sell its tech assets before the US will buy Spirent

    The US government will require Keysight Technologies to divest three of Spirent Communications’ businesses to resolve antitrust concerns before it buys the British company, a purchase originally valued at $1.5 billion.

    D.C., federal court, the US Department of Justice said the divested assets include Spirent’s high-speed ethernet testing, network security testing, and radio frequency channel emulation businesses.

    Keysight said in March it planned to sell those businesses to Viavi Solutions, once known as JDS Uniphase, for as much as $425 million in cash.

    The Justice Department said Keysight and Spirent together account for 85% of the high-speed ethernet testing market, more than 60% of the network security market, and more than 50% of radio frequency channel emulation.

    It said a merger without the divestitures might substantially lessen competition and harm customers.

    Based in Santa Rosa, California, Keysight agreed in March 2024 to buy Crawley, U.K.-based Spirent for 1.16 billion British pounds, now about $1.57 billion.

    Viavi had agreed earlier that month to buy Spirent, but was outbid by Keysight. Reuters

  • AI tool is introduced by the US FDA to reduce the length of scientific reviews

    AI tool is introduced by the US FDA to reduce the length of scientific reviews

    The US Food and Drug Administration (FDA) launched Elsa, a generative Artificial Intelligence (AI) tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people.

    “Following a very successful pilot program with FDA’s scientific reviewers, I set an aggressive timeline to scale AI agency-wide by June 30,” said FDA Commissioner Marty Makary, M.D., M.P.H. “Today’s rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers.”

    Built within a high-security GovCloud environment, Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff.

    “Today marks the dawn of the AI era at the FDA with the release of Elsa, AI is no longer a distant promise but a dynamic force enhancing and optimizing the performance and potential of every employee,” said FDA Chief AI Officer Jeremy Walsh. “As we learn how employees are using the tool, our development team will be able to add capabilities and grow with the needs of employees and the agency.”

    The agency is already using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations, and identify high-priority inspection targets.

    Elsa is a large language model–powered AI tool designed to assist with reading, writing, and summarizing. It can summarize adverse events to support safety profile assessments, perform faster label comparisons, and generate code to help develop databases for nonclinical applications. These are just a few examples of how Elsa will be used across the enterprise to improve operational efficiency.

    The introduction of Elsa is the initial step in the FDA’s overall AI journey. As the tool matures, the agency has plans to integrate more AI in different processes, such as data processing and generative-AI functions to further support the FDA’s mission.

    Prioritizing efficiency and responsibility, the FDA launched Elsa ahead of schedule using an all-center approach. Leaders and technologists across the agency collaborated, demonstrating the FDA’s ability to transform its operations through AI. Reuters

  • Up 58% from the April low, Bharti Hexacom soars to its highest level ever

    Up 58% from the April low, Bharti Hexacom soars to its highest level ever

    Shares of Bharti Hexacom hit a new high of ₹1,933.45, as they rallied 4.5 per cent on the BSE in Tuesday’s intra-day trade in an otherwise weak market on a healthy business outlook.

    The stock price of telecom services provider was quoting higher for the seventh straight trading day, surging 16 per cent during this period. It has bounced back 58 per cent from its three-month low of ₹1,225 touched on April 7, 2025.

    At 10:22 AM; Bharti Hexacom was quoting 3 per cent higher at ₹1,908.35, as compared to 0.07 per cent rise in the BSE Sensex.

    Bharti Hexacom’s Q4 results
    In the January to March 2025 quarter, the company’s consolidated revenues came in at ₹47,876 crore and this was impacted by a decline in B2B segment, which was in line with what the company guided last quarter to focus on quality revenues. India revenues, excluding Indus, came in at ₹33,100 crore. Earnings before interest, tax, depreciation and amortisation (Ebitda) margins came in at 50.7 per cent, this is an improvement of 1.4 per cent. The company said it prepaid another tranche of high cost Department of Telecommunications (DoT) spectrum debt of ₹5,985 crore.

    Healthy business outlook
    Analysts expect Bharti Hexacom’s Ebitda margin to further improve, driven by strong average revenue per user (ARPU) growth on account of tariff hikes, Bharti’s premiumisation strategy and cost optimisation via its ‘war on waste’ initiative.

    Analysts at JM Financial Institutional Securities believe India’s wireless business tariff hikes are likely to be more frequent, going forward, given the consolidated industry structure and higher ARPU requirement for Jio also to justify significant 5G capex and given Jio’s potential IPO.

    ARPU growth aided by likely moderation in capex will continue to drive Bharti Heaxacom’s FCF growth, enabling it to get to net cash by FY29; this will also aid in accretion in equity value. The brokerage firm sees Bharti Hexacom as a midcap pure-play on the structural wireless ARPU growth story.

    Bharti Hexacom provides a pure-play exposure to Bharti Airtel’s fast-growing India wireless and home broadband segments. Given the relatively lower penetration of mobile and fixed broadband in Bharti Hexacom’s circles, its growth prospects are slightly better than Airtel’s.

    Given lower teledensity and lower internet penetration in Hexacom circles (vs. pan-India), analysts believe Hexacom can potentially grow a few percentage points faster than Airtel on both subscribers and ARPU. Further, with significantly lower penetration of fixed broadband in Hexacom’s circles and the recent ramp-up of Fixed Wireless Access (FWA) offerings, analysts believe Hexacom’s wired broadband business could also grow at a faster clip.

    Motilal Oswal Financial Services believes Bharti Hexacom should command a premium to Airtel, given its slightly higher growth, better RoCEs, and lower capital misallocation concerns, and ascribe a DCF-based Jun’27E EV/EBITDA of 14.5x to Bharti Hexacom. However, currently, the stock is trading above brokerage firm’s target price of ₹1,900 per share. Business Standard

  • US funding sanctions affects African malaria prevention initiatives

    US funding sanctions affects African malaria prevention initiatives

    The “catastrophic” freeze on US funding for malaria has halted prevention programmes across Africa and also threatens to stall advances in genomic research, says Jane Carlton, director of the Johns Hopkins Malaria Research Institute.

    The US President’s Malaria Initiative (PMI) is one of numerous USAID-supported programmes to see its funding terminated under US President Donald Trump’s sweeping reforms this year.

    From eco-friendly bacterial pellets that kill mosquito larvae, to gene-drive mosquitoes that suppress wild populations, scientists are developing an arsenal of promising new technologies to combat malaria.

    “But without sustained funding, even the best tools stall”, says Carlton, warning that a retreat from funding could jeopardise decades of progress. SciDev.Net

  • EU should restrict procurement contracts for Chinese MedTech companies

    EU should restrict procurement contracts for Chinese MedTech companies

    The European Union is set to curb Chinese medical device manufacturers’ access to public procurement contracts in the bloc, according to a person familiar with the matter.

    EU countries are due to vote on the proposed measure as early as Monday, said the person, who spoke on condition of anonymity to discuss private deliberations.

    The move, if backed by member states, would be the first action taken by the EU based on its International Procurement Instrument, a 2022 law that’s meant to promote reciprocity in access to public procurement markets. Implementation of the restrictions could open a new front with China, just as the EU seeks to strike a balance in its relationship with Beijing while navigating US President Donald Trump’s tariff war.

    A spokesperson for the European Commission, the EU’s executive arm, didn’t immediately reply to a request for comment.

    The EU launched an investigation into China’s procurement of medical devices last April, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported.

    Beijing’s focus on local and state-oriented procurement in medical technologies has increased in recent years, as authorities across the country included strict domestic product requirements for many categories of device. The shift turned a €1.3 billion trade deficit in these goods for China in 2019 into a €5.2 billion surplus just one year later, according to data cited in an EU report published last April. The focus of the investigation wasn’t to reverse that trend but to enable fair competition.

    The EU has long argued that Beijing has been pushing market-distorting measures and practices to implement its “Made in China” policy and its target of achieving 85% domestic market share for Chinese companies producing “core medical device components” by 2025. The target is 70% for higher-end devices.

    The IPI allows the commission to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from procurement contracts. Bloomberg

  • Hospital OPDs in India have seen a triple rise in tourists amid the COVID-19 pandemic

    Hospital OPDs in India have seen a triple rise in tourists amid the COVID-19 pandemic

    It’s never a dull moment in hospitals across India and with Covid-19 infections rising across the country, hospitals are seeing a rise in footfalls in the outpatient departments (OPDs). India’s coronavirus burden is rising on a daily basis with many patients rushing to the hospital, fearing the worst.

    Several states in India are recording a spike in coronavirus infections — on Monday (June 2), India’s active Covid-19 cases stand at 3,961 with 203 new cases being added only on Sunday. That’s not it; the country is also recording a rise in Covid-related deaths — four have been reported since Sunday.

    So, what’s going on? How bad is the situation?

    India’s Covid burden keeps rising
    As of Monday (June 2), the country’s active Covid cases are 3,961 — more than a 15-fold increase in just 10 days, according to the data from the Ministry of Health and Family Welfare. Health authorities attribute the rapid increase to the emergence of new, more transmissible Omicron sub-variants, specifically NB.1.8.1 and NF.7 , predominantly affecting southern and western India.

    Data shows that the most cases have been detected in Kerala — 1,435 cases — whereas Maharashtra comes in second with 506 Covid cases. Delhi with 483 infections comes in third while Gujarat recorded 338 cases, coming in fourth. West Bengal (331), Karnataka (253), Tamil Nadu (189) and Uttar Pradesh (157) are the other states where Covid infections are being recorded in high numbers.

    Along with the rising infections, Covid deaths are also being reported in the country. Four deaths — one each in Delhi, Kerala, Maharashtra, and Tamil Nadu have been reported across the country in the past 24 hours.

    Indian Council of Medical Research (ICMR) Director General Dr Rajiv Bahl was quoted as telling the media that the rise in cases began in southern states, followed by western and now northern regions. The ICMR is closely monitoring the situation through the Integrated Disease Surveillance Programme (IDSP), he said.

    He further added, “The variants we have sequenced from South and West India are not much severe. Four variants have been discovered — LF.7 series, XFG series, JN.1 series and NB.1.8.1 series in the same order. We are sequencing the samples from other areas to check for more new variants… The cases are not very severe and people should not worry, but only stay vigilant.”

    OPD admissions in hospitals increase
    And as a result of the increasing Covid cases, patient footfall at OPDs is rising by at least three to four times. Dr Pradeep Bajad, senior consultant, pulmonary, critical care, and sleep medicine at Faridabad-based Amrita Hospital, told News18, “At present, we are not seeing a surge in ICU admissions due to Covid-19 directly. However, we are witnessing a marked increase in OPD footfall, with patient visits increasing by nearly three to four times in the past 10 days.”

    Dr Suranjit Chatterjee, senior consultant, internal medicine at Indraprastha Apollo Hospitals, also noted a rise in patients visiting the OPD. He also stated that most of those who are visiting the OPD are complaining of fever, sore throat, and upper respiratory symptoms, which he calls routine and manageable.

    Dr Arup Halder, consultant pulmonologist at CMRI Hospital, Kolkata, also said that there was a significant rise in OPD consultations. People with fever and cold-like symptoms are walking in to get themselves checked out, he was quoted as saying.

    The rising infections have also got hospital authorities on high alert; they are ramping up preventive measures such as increased Covid testing and preparation of hospital beds. In fact, many hospitals across the country are preparing isolation wards amid the Covid spike. For instance, in Haryana, officials have been asked to ensure hospitals establish dedicated flu corners and maintain adequate isolation beds, oxygen supplies, PPE kits, N95 masks, antibiotics, and testing kits.

    At the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, special wards for Covid-19 patients, including ICU beds and high-dependency units, have been activated. A similar picture is prevalent in Karnataka wherein hospitals are preparing bigger and better isolation wards.

    Covid symptoms to watch out for
    Doctors note that most of the patients being diagnosed with Covid have the usual symptoms — fever, sore throat, cough, cold, headache, body ache and fatigue. However, this time there’s one specific symptom that could help patients discern if they are infected and that’s having diarrhoea, especially watery diarrhoea.

    “Many are coming in with diarrhoea. Painless, watery stools for a day or two followed by severe lethargy or fatigue. Lethargy can persist for weeks post-discharge from the hospital. So, any patient who presents with unexplained diarrhoea, check for Covid-19,” Dr Chatterjee was quoted as telling News18.

    Doctors note that this change may be due to the virus’s altered behaviour in the body or its interaction with the gut’s immune system.

    Dr Charudatt Vaity, director of critical care at Fortis Hospital Mulund, also noted that an increasing number of patients with runny diarrhoea were testing positive for Covid.

    Doctors calls for extra vigilance
    But despite the rise in cases, doctors are of the opinion that the situation is still under control and that there is no need to panic. However, medical experts have called for an increase in vigilance. Dr Sanjay Jain, dean research, PGIMER, said, “Most new variant cases are mild, but vigilance is essential, especially to protect the vulnerable.”

    Even Union Minister of State for Health and AYUSH (Independent Charge), Prataprao Jadhav, assured that the Centre is fully prepared to handle any situation that may arise. “Both our Central Health Department and the AYUSH Ministry are fully alert and closely monitoring the situation across all states. We have spoken with the respective Health and AYUSH Secretaries, as well as other concerned ministers,” Jadhav was quoted as telling news agency ANI.

    Soumya Swaminathan , former chief scientist at the World Health Organisation (WHO), also echoed similar sentiments. She has urged the public to stay cautious but not to panic. Speaking to News18, she said that the current trends do not indicate a return to the devastating waves of 2020 or 2021.

    “Covid or SARS-CoV-2, which is the virus, is another respiratory virus, like the many others that are circulating amongst us human beings in the world today. It has been around for five years now. It’s, of course, constantly mutating and changing, like other viruses,” she said.

    She further added, “What you’re seeing now is a mild disease mostly. Even though people are testing and reporting positivity, you find that hospitalisations are rare.” FIRSTPOST

  • Vodafone plans to release the Q4 figures today

    Vodafone plans to release the Q4 figures today

    Cash-strapped telecom service provider Vodafone Idea Ltd. will be reporting its March quarter results on Friday, May 30.

    Along with the quarterly results, Vodafone Idea’s board will also be evaluating proposals to raise funds through various methods.

    “To consider and evaluate any and all proposals for raising of funds in one or more tranches, either by way of a rights issue or a Further Public Offer (FPO) or a private placement, including a preferential issue or a QIP, through any other permissible mode and / or combination thereof as may be considered appropriate,” Vodafone Idea said in its exchange filing.

    As of date, Vodafone Idea has AGR dues to the tune of ₹83,400 crore, along with ₹1.19 lakh crore in Spectrum dues.

    The company had recently warned that without further government support, it will not be able to operate beyond financial year 2026 and head into the National Company Law Tribunal (NCLT).

    The government is currently the largest shareholder in Vodafone Idea, having converted a part of Vodafone Idea’s dues to equity, thereby taking its stake in the struggling telecom company to 48.99%.

    Vodafone Idea has close to 60 lakh retail shareholders, or those with authorised share capital of up to ₹2 lakh.

    Shares of Vodafone Idea have opened little changed on Wednesday at ₹6.96. The stock is at least 40% below its FPO price of ₹11, while it has declined over 65% from its 2024-peak of ₹19.18. CNBCTV18

  • In five years, India can be the world’s data capital

    In five years, India can be the world’s data capital

    With a 97 per cent fall in the price of data over the past 11 years, India is set to become the data capital of the world in the next five years, Telecom Minister Jyotiraditya Scindia said. India is already the second-largest mobile market globally, with 1.2 billion users and 974 million internet users, of whom 940 million are broadband users, he said.

    With 1 GB of data now costing ₹9 on average—down from ₹287 in 2014—the cost of communication has fallen by 97 per cent, Scindia said. India’s per GB data cost is only one-fifth of the global average, he added.

    India is also among the only five countries in the world to develop an indigenous 4G telecom stack. BSNL has installed close to 94,000 4G telecom towers.

    Scindia said he is committed to transforming India Post from a cost centre to a profit centre within the next five years, noting that it has the largest distribution network in the world with 1.64 lakh points of presence.

    “There is no reason why the post office can’t become a small mall. We are empowering every Grameen Dak Sevak with a handheld electronic payment device,” he said.

    North East rising
    Scindia, who also serves as Minister for the Ministry of Development of North Eastern Region, said the eight North Eastern states have seen a decadal compounded annual growth rate of 12–13 per cent, and are on course to becoming the economic powerhouse of the country.

    He said the recent North East Summit attracted ₹4.3 trillion worth of investment for the region.

    Highlighting infrastructure development, the Minister said the number of airports in the region has increased to 17, from 9 earlier. Weekly air traffic movements have more than doubled—from 980 a decade ago to about 2,200 now.

    The region is home to 38 per cent of India’s bamboo and 22 per cent of its rubber, and holds the greatest potential for the cultivation of Agarwood, used extensively in the perfume industry. “Around ₹1,000 crore of investment has been received for Agarwood cultivation in the North East,” Scindia said.

    He added that nine infrastructure projects worth ₹81,000 crore are currently under execution. The Centre is committed to developing Agartala and Guwahati as connectivity hubs for South East Asia, he said.

    “Up to $122 billion of trade currently conducted with ASEAN nations must be routed through the North East,” the minister said.

    He also noted that 6,000 km of highways and 2,000 km of railways have been built in the region over the past decade. Business Standard